EARNINGS: Poolbeg Pharma loss narrows; Zanaga Iron Ore loss widens
29th Sep 2026 20:03
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 7.10p on 06-10-2026 at 07:00:46 |
|---|---|
| Change | 0.10p 1.43% |
| Buy | 7.20p |
| Sell | 7.00p |
| Last Trade: | Sell 2,286.00 at 7.065p |
| Day's Volume: | 19,240 |
| Last Close: | 7.00p |
| Open: | 7.10p |
| ISIN: | GB00BKPG7Z60 |
| Day's Range | 7.10p - 7.10p |
| 52wk Range: | 3.30p - 9.15p |
| Market Capitalisation: | £54.20m |
| VWAP: | 7.12133p |
| Shares in Issue: | 763.44m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Poolbeg Pharma (POLB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,286 | 7.065p | Ordinary |
08:00:38 - 06-Oct-26 |
| Buy* | 2,500 | 7.14p | Ordinary |
08:00:21 - 06-Oct-26 |
| Buy* | 12,500 | 7.14p | Ordinary |
08:00:07 - 06-Oct-26 |
| Buy* | 95 | 7.20p | SI Trade |
08:00:01 - 06-Oct-26 |
| Sell* | 138 | 7.00p | SI Trade |
08:00:01 - 06-Oct-26 |
| Buy* | 277 | 7.20p | SI Trade |
08:00:01 - 06-Oct-26 |
| Buy* | 27 | 7.20p | SI Trade |
08:00:01 - 06-Oct-26 |
| Sell* | 136 | 7.00p | SI Trade |
08:00:01 - 06-Oct-26 |
| Buy* | 17 | 7.20p | SI Trade |
08:00:01 - 06-Oct-26 |
| Sell* | 558 | 7.00p | SI Trade |
08:00:01 - 06-Oct-26 |
Poolbeg Pharma (POLB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Sep 2026 7:00 am | RNS | Interim Results for the six months to 30 June 2026 |
| 28th Sep 2026 7:00 am | RNS-R | POLB 001 TOPICAL trial recruitment update |
| 24th Sep 2026 7:00 am | RNS | Interim data from POLB 001 TOPICAL clinical trial |
| 14th Sep 2026 11:58 am | RNS | Notification of Major Holdings |
| 3rd Sep 2026 7:00 am | RNS-R | Key Conference Participation in September 2026 |
| 23rd Jul 2026 11:05 am | RNS | Notification of major holdings |
| 22nd Jul 2026 7:00 am | RNS | Notification of Major Holdings |
| 21st Jul 2026 7:00 am | RNS-R | Notice of Allowance for POLB 001 patent in Israel |
| 14th Jul 2026 7:00 am | RNS | Placing to raise £3.5 million |
| 13th Jul 2026 7:00 am | RNS | First patient dosed in POLB 001 TOPICAL trial |